Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pearl Grimes

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Journal of Drugs in Dermatology : JDD|February 8, 2022
Histopathological Changes Induced by Malassezin: A Novel Natural Microbiome Indole for Treatment of Facial HyperpigmentationPearl Grimes, Jag Bhawan, Michael Howell, et al.
Journal of Drugs in Dermatology : JDD|December 2, 2025
Maximizing a Focused Vitiligo Patient Visit: A Practical ApproachAbrar Qureshi, Hira Ghani, Seemal Desai, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 16, 2024
Repigmentation by body region in patients with vitiligo treated with ruxolitinib cream over 52 weeksThierry Passeron, John E Harris, Amit G Pandya, et al.
American Journal of Clinical Dermatology|September 1, 2021
The Pathogenesis and Management of Acne-Induced Post-inflammatory HyperpigmentationNada Elbuluk, Pearl Grimes, Anna Chien, et al.
Journal of the American Academy of Dermatology|March 16, 2023
Treatment recommendations for acne-associated hyperpigmentation: Results of the Delphi consensus process and a literature reviewSusan Taylor, Nada Elbuluk, Pearl Grimes, et al.
JID Innovations : Skin Science From Molecules to Population Health|October 16, 2023
Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib CreamMichael D Howell, Fiona I Kuo, Beth Rumberger, et al.
Dermatology and Therapy|March 29, 2025
Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 StudiesJulien Seneschal, Albert Wolkerstorfer, Seemal R Desai, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 5, 2019
Polymethylmethacrylate Collagen Gel-Injectable Dermal Filler for Full Face Atrophic Acne Scar CorrectionJohn H Joseph, Ava Shamban, Laura Eaton, et al.
The American Journal of Dermatopathology|September 17, 2009
A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% creamJag Bhawan, Pearl Grimes, Amit G Pandya, et al.
Journal of Drugs in Dermatology : JDD|June 19, 2020
Long-Term Benefits of Daily Photo-Protection With a Broad-Spectrum Sunscreen in United States Hispanic Female PopulationPearl Grimes, Rebat Halder, Michele Verschoore, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Journal of Drugs in Dermatology : JDD|February 8, 2022
Histopathological Changes Induced by Malassezin: A Novel Natural Microbiome Indole for Treatment of Facial HyperpigmentationPearl Grimes, Jag Bhawan, Michael Howell, et al.
Journal of Drugs in Dermatology : JDD|December 2, 2025
Maximizing a Focused Vitiligo Patient Visit: A Practical ApproachAbrar Qureshi, Hira Ghani, Seemal Desai, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 16, 2024
Repigmentation by body region in patients with vitiligo treated with ruxolitinib cream over 52 weeksThierry Passeron, John E Harris, Amit G Pandya, et al.
American Journal of Clinical Dermatology|September 1, 2021
The Pathogenesis and Management of Acne-Induced Post-inflammatory HyperpigmentationNada Elbuluk, Pearl Grimes, Anna Chien, et al.
Journal of the American Academy of Dermatology|March 16, 2023
Treatment recommendations for acne-associated hyperpigmentation: Results of the Delphi consensus process and a literature reviewSusan Taylor, Nada Elbuluk, Pearl Grimes, et al.
JID Innovations : Skin Science From Molecules to Population Health|October 16, 2023
Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib CreamMichael D Howell, Fiona I Kuo, Beth Rumberger, et al.
Dermatology and Therapy|March 29, 2025
Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 StudiesJulien Seneschal, Albert Wolkerstorfer, Seemal R Desai, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 5, 2019
Polymethylmethacrylate Collagen Gel-Injectable Dermal Filler for Full Face Atrophic Acne Scar CorrectionJohn H Joseph, Ava Shamban, Laura Eaton, et al.
The American Journal of Dermatopathology|September 17, 2009
A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% creamJag Bhawan, Pearl Grimes, Amit G Pandya, et al.
Journal of Drugs in Dermatology : JDD|June 19, 2020
Long-Term Benefits of Daily Photo-Protection With a Broad-Spectrum Sunscreen in United States Hispanic Female PopulationPearl Grimes, Rebat Halder, Michele Verschoore, et al.
Pageof 6